Author Archives: budd87309@gmail.com
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.
Trump officials believed to be WHCD gunman’s target, acting AG says Axios Grievance Propelled Gala Attack Suspect Across Country, Authorities Say The New York Times White House press dinner shooting raises questions over security at event The Guardian DC gala shooting suspect aired grievances against Trump in writings to family AP News Alleged White House Correspondents’ Dinner shooter set […]
Trump officials hire ‘deportation judges’ with less training, experience The Washington Post
Grievance Propelled Gala Attack Suspect Across Country, Authorities Say The New York Times Security has long been top of mind for Melania Trump. She faced those concerns in a new way this weekend CNN DC gala shooting suspect aired grievances against Trump in writings to family AP News Correspondents’ dinner lacked highest security level despite presence of top […]
Read the full transcript of Norah O’Donnell’s interview with President Trump here CBS News Trump lashes out at ‘60 Minutes’ anchor for reading alleged gunman’s manifesto Politico Trump to Appear on ’60 Minutes’ After Correspondents Dinner Shooting Variety Trump lashes out at “60 Minutes” for asking about gunman manifesto allegations Axios Trump angrily denies he’s a ‘pedophile’ over shooting […]
Iranian foreign minister heads to Russia, Trump says ‘call us’ to negotiate Reuters Live updates: Iran’s top diplomat in Russia for Putin meeting as US peace talks stall CNN Top Iranian Official in Russia for Talks With Putin on Middle East War The New York Times Iran war: What’s happening on day 59 amid diplomatic push to end […]
China said Monday it has decided to block Meta’s $2 billion acquisition of Manus, a Singaporean AI startup with Chinese roots.
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.